Skip to main content
Fig. 3 | Biomaterials Research

Fig. 3

From: A drug delivery system constructed by a fusion peptide capturing exosomes targets to titanium implants accurately resulting the enhancement of osseointegration peri-implant

Fig. 3

PEP3 does not alter characteristics of exosomes. A The shape of EXO and EXO-PEP3 was analyzed by TEM. Right panels represented the corresponding magnified boxed areas from left panels. B The size of EXO and EXO-PEP3 was analyzed by NTA. C Western blot results examined the expression of exosomal markers CD9, CD81, CD63 and Alix on the exosomes and EXO-PEP3. D Flow cytometry to confirm the modification efficiency of EXO with PEP3. E Flow cytometry to compare the modification efficiency on EXO of PEP3 and CP05. Rhodamine-labeled peptides were used

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us